Logo (Actavis) 155 Pill - white round, 10mm
Pill with imprint Logo (Actavis) 155 is White, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base). It is supplied by Actavis Elizabeth LLC.
Buprenorphine/naloxone is used in the treatment of Opioid Use Disorder and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images for Logo (Actavis) 155
Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)
- Imprint
- Logo (Actavis) 155
- Strength
- 8 mg (base) / 2 mg (base)
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Narcotic analgesic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Actavis Elizabeth LLC
- National Drug Code (NDC)
- 00228-3155
- Inactive Ingredients
-
citric acid anhydrous,
lactose monohydrate,
magnesium stearate,
mannitol,
corn starch,
povidone k30,
trisodium citrate dihydrate,
sucralose
Note: Inactive ingredients may vary.
See also:
More about buprenorphine / naloxone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,133)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: narcotic analgesic combinations
- En español
Patient resources
- Buprenorphine and naloxone oral/sublingual drug information
- Buprenorphine/naloxone (Advanced Reading)
Other brands
Suboxone, Zubsolv, Bunavail, Cassipa
Professional resources
- Buprenorphine Buccal Film prescribing information
- Buprenorphine and Naloxone Sublingual Film (FDA)
- Buprenorphine and Naloxone Sublingual Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.